Overview

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
There is currently no standard treatment to prevent burn depth conversion in partial-thickness burns. Conversion into deeper wounds is associated with higher complications and morbidity. The most common theory attributes this depth conversion to the prolonged inflammatory response that occurs after burn injury. Therefore, the investigators propose testing the safety and efficacy of tacrolimus ointment (an immunosuppressive agent) in patients with deep partial-thickness burns.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
Tacrolimus